
Phaarmasia Hits New 52-Week High of Rs.76.1, Marking Strong Momentum
2025-12-04 09:58:42Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.76.1 today, reflecting a sustained rally and robust market momentum over the past several weeks.
Read More
Phaarmasia Surges to Upper Circuit Amid Unprecedented Buying Interest
2025-12-04 09:35:38Phaarmasia Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s uninterrupted rally and absence of sellers suggest a potential multi-day circuit scenario, underscoring robust investor enthusiasm in the Pharmaceuticals & Biotechnology sector.
Read More
Phaarmasia Hits New 52-Week High of Rs.72.48 Marking Strong Momentum
2025-12-03 09:56:29Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.72.48 today, reflecting a sustained upward trajectory over the past fortnight. This milestone underscores the stock's robust momentum amid a mixed market environment.
Read More
Phaarmasia Surges to Upper Circuit with Unprecedented Buying Interest
2025-12-03 09:30:28Phaarmasia Ltd has captured market attention by hitting its upper circuit limit today, with an extraordinary buying momentum and no sellers in the queue. The stock opened at its new 52-week high of ₹72.48 and has maintained this price throughout the trading session, signalling a potential multi-day circuit scenario driven by sustained demand in the Pharmaceuticals & Biotechnology sector.
Read More
Phaarmasia Hits New 52-Week High of Rs.69.03, Marking Strong Momentum
2025-12-02 09:56:35Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.69.03 today, reflecting a sustained rally that has captured market attention. The stock’s performance over the past fortnight underscores a notable momentum in an otherwise cautious market environment.
Read More
Phaarmasia Surges to Upper Circuit with Unprecedented Buying Interest
2025-12-02 09:35:37Phaarmasia Ltd has witnessed extraordinary buying momentum, hitting its upper circuit limit today with no sellers in the queue. The pharmaceutical and biotechnology stock has recorded a remarkable 4.99% gain intraday, opening and trading at its new 52-week high of ₹69.03, signalling a potential multi-day circuit scenario driven by sustained demand and investor enthusiasm.
Read More
Phaarmasia Hits New 52-Week High of Rs.65.75 Marking Strong Momentum
2025-12-01 11:14:18Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.65.75 today, reflecting sustained momentum and notable gains over the past several weeks. This milestone underscores the stock’s robust performance relative to its sector and broader market indices.
Read More
Phaarmasia Surges to Upper Circuit with Unprecedented Buying Interest
2025-12-01 09:30:30Phaarmasia Ltd has captured market attention by hitting the upper circuit limit today, with an extraordinary influx of buy orders and no sellers in the queue. This rare scenario underscores a powerful buying momentum that could extend over multiple trading sessions, reflecting robust investor confidence in the pharmaceuticals and biotechnology sector.
Read More
Phaarmasia Hits New 52-Week High of Rs.62.62, Marking Strong Momentum
2025-11-28 09:42:42Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching a new 52-week high of Rs.62.62. This achievement reflects a sustained period of positive momentum, with the stock demonstrating robust performance over recent weeks.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
16-Jan-2026 | Source : BSECertificate under Reg 74(5) of SEBI(Depositories and Participants) Regulations 2018 for the Quarter ended 31st December 2025
Closure of Trading Window
29-Dec-2025 | Source : BSEClosure of trading Window for dealing in the securities of the company will remain closed from January 01st 2026 till 48hrs of the declaration of unaudited Financial Statements for the Quarter ended December 31st 2025.
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSENewspaper Publication of the Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available